Following best practices for SN EN ISO 10993-17:2023 compliance is crucial for ensuring the safety and effectiveness of medical devices, as well as for maintaining audit readiness.

Best practices at a glance

This section outlines several best practices that align with the requirements of SN EN ISO 10993-17:2023. The checklist includes practices that address toxicological risk assessment, chemical characterization, risk evaluation criteria, and exposure assessment, ensuring thorough compliance with ISO 10993-1 standards.

The practices

1. Conduct Comprehensive Chemical Characterization: Ensure that all constituents of the medical device undergo detailed chemical characterization. This is essential for identifying potential toxicological risks and aligning with the requirements set forth in Clause 4.1 of SN EN ISO 10993-17:2023. By understanding the chemical makeup, manufacturers can better evaluate hazards and mitigate risks.

2. Implement Rigorous Toxicological Risk Assessments: Establish a robust toxicological risk assessment procedure as per Clause 5.3. This practice helps in systematically evaluating the potential toxic effects of device constituents. A thorough risk assessment not only aligns with ISO 10993-1 compliance but also enhances patient safety by preventing adverse health outcomes.

3. Define and Apply Tolerable Contact Doses: Clearly define tolerable contact doses for all materials used in the device according to Clause 6.2. This practice ensures that exposure levels remain within safe limits, thereby minimizing the risk of toxic effects. It is crucial for obtaining ISO 10993-1 certification for medical devices as it demonstrates an understanding of acceptable exposure levels.

4. Identify and Screen for Hazardous Constituents: Regularly update the list of hazardous constituents based on the latest scientific data, following Clause 4.2. This practice is critical for hazard identification and helps in risk estimation, which is a key component of ISO 10993-1 compliance. By actively screening for hazards, manufacturers can preemptively address potential issues.

5. Evaluate Human Carcinogens: Conduct evaluations to identify any components that may be classified as human carcinogens, as outlined in Clause 6.3. This practice is vital for ensuring that the medical devices do not pose cancer risks, thereby fostering trust and compliance with international health regulations.

6. Utilize Toxicological Screening Thresholds: Establish and utilize toxicological screening thresholds in line with Clause 5.4. This aids in differentiating between materials that require further testing and those that may be considered safe, streamlining the certification process while ensuring compliance with ISO 10993-1 standards.

7. Document All Assessment Processes Thoroughly: Maintain meticulous documentation of all toxicological assessments and evaluations as specified in Clause 7. This practice not only supports internal audits but also fulfills regulatory documentation requirements, ensuring ISO 10993-1 compliance.

8. Engage in Continuous Training and Education: Regularly train your team on ISO 10993-1 compliance requirements, as continuous education is essential for adapting to new regulations and standards. This practice strengthens the organization’s ability to maintain compliance and promote biocompatibility in medical devices.

Audit preparation checklist

• Conduct comprehensive chemical characterization of all device constituents.
• Implement rigorous toxicological risk assessments.
• Define and apply tolerable contact doses for materials.
• Identify and screen for hazardous constituents regularly.
• Evaluate human carcinogens associated with device materials.
• Utilize toxicological screening thresholds for risk management.
• Document all assessment processes thoroughly.
• Engage in continuous training and education for compliance.

Next steps

To deepen your understanding of ISO 10993-1 compliance, consider engaging in specialized training, implementing an in-depth guide for compliance, or purchasing the SN EN ISO 10993-17:2023 standard for detailed insights into the requirements and best practices.